Date published: 2026-7-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

GPR32 Double Nickase Plasmid (h): sc-405309-NIC

0.0(0)
Write a reviewAsk a question

Datasheets
  • Target species: human
  • 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
  • GPR32 Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
  • Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
  • One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
  • GPR32 Double Nickase Plasmid (h) and GPR32 Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting GPR32. One or both designs may be available
    Gene Editing Promo Banner

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    GPR32 Double Nickase Plasmid (h)

    sc-405309-NIC
    20 µg
    $410.00

    Human GPR32 encodes an orphan G protein-coupled receptor implicated in sensing pro-resolving lipid mediators and shaping the magnitude and duration of inflammatory responses. Reported signaling links include GPCR-driven modulation of second messenger pathways and downstream transcriptional programs that influence leukocyte trafficking, cytokine production, and macrophage functional states. GPR32 activity has been associated with resolution-phase immune processes, intersecting with pathways that control chemotaxis, cell survival, and tissue homeostasis. Altered expression or signaling context for GPR32 has been explored in inflammation-related conditions, making it a useful target for mechanistic studies of immune regulation.

    GPR32 Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the GPR32 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within GPR32. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt GPR32 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.

    To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of GPR32-disrupted clones.

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.